Reaction
Extradural Haematoma reporting signals
As of the last recalculation, Extradural Haematoma appears in 1,312 FAERS reports alongside 31 co-occurring drug terms. The strongest observed disproportionality signal is BUPIVACAINE (PRR 64.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bupivacaine | 37 | 64.6 | 64.9 |
| Fondaparinux Sodium | 26 | 52.0 | 52.1 |
| Heparin Sodium | 40 | 47.6 | 47.7 |
| Enoxaparin Sodium | 73 | 21.3 | 21.3 |
| Clopidogrel Bisulfate | 118 | 20.0 | 20.0 |
| Iohexol | 10 | 19.3 | 19.3 |
| Dalteparin Sodium | 10 | 15.1 | 15.1 |
| Warfarin Sodium | 41 | 14.4 | 14.5 |
| Emicizumab | 11 | 14.2 | 14.2 |
| Lidicaine | 39 | 13.0 | 13.0 |
| Burn Relief | 39 | 13.0 | 13.0 |
| Lidocaine Hydrochloride And Epinephrine | 39 | 13.0 | 13.0 |
| Lidocaine, Menthol | 39 | 12.8 | 12.8 |
| Warfarin | 94 | 12.6 | 12.6 |
| Clopidogrel | 141 | 12.5 | 12.5 |
| Alteplase | 11 | 11.7 | 11.7 |
| Dexamethasone Sodium Phosphate | 7 | 11.0 | 11.0 |
| Rivaroxaban | 123 | 10.2 | 10.2 |
| Dabigatran Etexilate Mesylate | 45 | 10.1 | 10.1 |
| Dabigatran Etexilate | 46 | 9.7 | 9.7 |
| Sevoflurane | 5 | 9.6 | 9.6 |
| Romosozumab-Aqqg | 7 | 8.2 | 8.2 |
| Rocuronium Bromide | 6 | 8.1 | 8.1 |
| Dronedarone | 5 | 7.8 | 7.8 |
| Pitavastatin Calcium | 5 | 7.8 | 7.8 |
| Blinatumomab | 5 | 7.6 | 7.6 |
| Apixaban | 30 | 7.3 | 7.3 |
| Rasagiline Mesylate | 5 | 7.1 | 7.2 |
| Pegaspargase | 5 | 6.5 | 6.5 |
| Ethyl Alcohol | 11 | 6.5 | 6.5 |
| Alcohol | 11 | 4.5 | 4.5 |